Xiongwei Hu
Papers
1
Total Citations
14
H-Index
1
About
Dr. Xiongwei Hu is a leading hepatobiliary surgeon whose research focuses on advancing minimally invasive liver surgery, particularly for hepatocellular carcinoma (HCC). His major contributions center on comparing the efficacy and safety of robotic versus laparoscopic liver resection, addressing a critical gap in long-term outcome evidence. In his landmark 2024 propensity score-matched cohort study, which has already garnered 14 citations, Dr. Hu demonstrated that robotic liver resection offers comparable oncologic outcomes to laparoscopic approaches, with potential advantages in complex resections. This work provides crucial data for surgical decision-making and has helped establish robotic techniques as a viable option in HCC treatment. His research impacts the field by offering rigorous, evidence-based comparisons that guide clinical practice and improve patient outcomes. Dr. Hu’s dedication to refining surgical methodologies and generating high-quality retrospective evidence positions him as an influential voice in the evolution of minimally invasive hepatobiliary surgery, with his findings increasingly referenced by surgeons and researchers worldwide.
Research Focus
Key Achievements
Top Papers
- 1